209 related articles for article (PubMed ID: 27896996)
1. CERNA SEARCH METHOD IDENTIFIED A MET-ACTIVATED SUBGROUP AMONG EGFR DNA AMPLIFIED LUNG ADENOCARCINOMA PATIENTS.
Kabat H; Tunkle L; Lee I
Pac Symp Biocomput; 2017; 22():438-448. PubMed ID: 27896996
[TBL] [Abstract][Full Text] [Related]
2. Identification of module biomarkers from the dysregulated ceRNA-ceRNA interaction network in lung adenocarcinoma.
Shao T; Wu A; Chen J; Chen H; Lu J; Bai J; Li Y; Xu J; Li X
Mol Biosyst; 2015 Nov; 11(11):3048-58. PubMed ID: 26325208
[TBL] [Abstract][Full Text] [Related]
3. Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers.
Chiu YC; Hsiao TH; Chen Y; Chuang EY
BMC Genomics; 2015; 16 Suppl 4(Suppl 4):S1. PubMed ID: 25917195
[TBL] [Abstract][Full Text] [Related]
4. Cancerin: A computational pipeline to infer cancer-associated ceRNA interaction networks.
Do D; Bozdag S
PLoS Comput Biol; 2018 Jul; 14(7):e1006318. PubMed ID: 30011266
[TBL] [Abstract][Full Text] [Related]
5. LINC00467 Is Upregulated by DNA Copy Number Amplification and Hypomethylation and Shows ceRNA Potential in Lung Adenocarcinoma.
Wang W; Bo H; Liang Y; Li G
Front Endocrinol (Lausanne); 2021; 12():802463. PubMed ID: 35095769
[TBL] [Abstract][Full Text] [Related]
6. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
7. MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.
Beau-Faller M; Ruppert AM; Voegeli AC; Neuville A; Meyer N; Guerin E; Legrain M; Mennecier B; Wihlm JM; Massard G; Quoix E; Oudet P; Gaub MP
J Thorac Oncol; 2008 Apr; 3(4):331-9. PubMed ID: 18379349
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status.
Kim H; Yang JM; Jin Y; Jheon S; Kim K; Lee CT; Chung JH; Paik JH
Oncotarget; 2017 Jan; 8(5):8484-8498. PubMed ID: 28035073
[TBL] [Abstract][Full Text] [Related]
9. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
[TBL] [Abstract][Full Text] [Related]
10. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
[TBL] [Abstract][Full Text] [Related]
12. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
[TBL] [Abstract][Full Text] [Related]
13. IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
Hintzsche J; Kim J; Yadav V; Amato C; Robinson SE; Seelenfreund E; Shellman Y; Wisell J; Applegate A; McCarter M; Box N; Tentler J; De S; Robinson WA; Tan AC
J Am Med Inform Assoc; 2016 Jul; 23(4):721-30. PubMed ID: 27026619
[TBL] [Abstract][Full Text] [Related]
14. The gain and loss of long noncoding RNA associated-competing endogenous RNAs in prostate cancer.
Liu D; Yu X; Wang S; Dai E; Jiang L; Wang J; Yang Q; Yang F; Zhou S; Jiang W
Oncotarget; 2016 Aug; 7(35):57228-57238. PubMed ID: 27528026
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
16. The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients.
Hong JH; Roh KS; Suh SS; Lee S; Sung SW; Park JK; Byun JH; Kang JH
Tumour Biol; 2015 Dec; 36(12):9327-37. PubMed ID: 26104764
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
18. Competing endogenous RNAs in lung cancer.
Zhao M; Feng J; Tang L
Cancer Biol Med; 2021 Feb; 18(1):1-20. PubMed ID: 33628581
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of differentially expressed profiles of lncRNAs and construction of miR-133b mediated ceRNA network in colorectal cancer.
Wu H; Wu R; Chen M; Li D; Dai J; Zhang Y; Gao K; Yu J; Hu G; Guo Y; Lin C; Li X
Oncotarget; 2017 Mar; 8(13):21095-21105. PubMed ID: 28177879
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer.
Zhen Q; Liu J; Gao L; Liu J; Wang R; Chu W; Zhang Y; Tan G; Zhao X; Lv B
Cytogenet Genome Res; 2015; 146(1):1-8. PubMed ID: 26184032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
